These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 21930290)
21. Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies. Li H; Tsui TY; Ma W Int J Mol Sci; 2015 Aug; 16(8):19518-36. PubMed ID: 26295227 [TBL] [Abstract][Full Text] [Related]
27. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Akinc A; Zumbuehl A; Goldberg M; Leshchiner ES; Busini V; Hossain N; Bacallado SA; Nguyen DN; Fuller J; Alvarez R; Borodovsky A; Borland T; Constien R; de Fougerolles A; Dorkin JR; Narayanannair Jayaprakash K; Jayaraman M; John M; Koteliansky V; Manoharan M; Nechev L; Qin J; Racie T; Raitcheva D; Rajeev KG; Sah DW; Soutschek J; Toudjarska I; Vornlocher HP; Zimmermann TS; Langer R; Anderson DG Nat Biotechnol; 2008 May; 26(5):561-9. PubMed ID: 18438401 [TBL] [Abstract][Full Text] [Related]
28. Synthetic SiRNA Delivery: Progress and Prospects. Roberts TC; Ezzat K; El Andaloussi S; Weinberg MS Methods Mol Biol; 2016; 1364():291-310. PubMed ID: 26472459 [TBL] [Abstract][Full Text] [Related]
29. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors. Sun Y; Li Z; Li L; Li J; Liu X; Li W Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648 [TBL] [Abstract][Full Text] [Related]
30. Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivo. Hassler MR; Turanov AA; Alterman JF; Haraszti RA; Coles AH; Osborn MF; Echeverria D; Nikan M; Salomon WE; Roux L; Godinho BMDC; Davis SM; Morrissey DV; Zamore PD; Karumanchi SA; Moore MJ; Aronin N; Khvorova A Nucleic Acids Res; 2018 Mar; 46(5):2185-2196. PubMed ID: 29432571 [TBL] [Abstract][Full Text] [Related]
31. Peptide vectors for the nonviral delivery of nucleic acids. Hoyer J; Neundorf I Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499 [TBL] [Abstract][Full Text] [Related]
32. Synthesis of PLGA-Lipid Hybrid Nanoparticles for siRNA Delivery Using the Emulsion Method PLGA-PEG-Lipid Nanoparticles for siRNA Delivery. Wang L; Griffel B; Xu X Methods Mol Biol; 2017; 1632():231-240. PubMed ID: 28730443 [TBL] [Abstract][Full Text] [Related]
33. GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics. Springer AD; Dowdy SF Nucleic Acid Ther; 2018 Jun; 28(3):109-118. PubMed ID: 29792572 [TBL] [Abstract][Full Text] [Related]
34. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges. Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781 [TBL] [Abstract][Full Text] [Related]
36. RNAi in functional genomics. Scherr M; Eder M Curr Opin Mol Ther; 2004 Apr; 6(2):129-35. PubMed ID: 15195923 [TBL] [Abstract][Full Text] [Related]
37. Advances in RNAi therapeutic delivery to leukocytes using lipid nanoparticles. Ramishetti S; Landesman-Milo D; Peer D J Drug Target; 2016 Nov; 24(9):780-786. PubMed ID: 27030014 [TBL] [Abstract][Full Text] [Related]
38. The spacer arm length in cell-penetrating peptides influences chitosan/siRNA nanoparticle delivery for pulmonary inflammation treatment. Jeong EJ; Choi M; Lee J; Rhim T; Lee KY Nanoscale; 2015 Dec; 7(47):20095-104. PubMed ID: 26568525 [TBL] [Abstract][Full Text] [Related]
39. Multifunctional peptide-lipid nanocomplexes for efficient targeted delivery of DNA and siRNA into breast cancer cells. Wan Y; Dai W; Nevagi RJ; Toth I; Moyle PM Acta Biomater; 2017 Sep; 59():257-268. PubMed ID: 28655658 [TBL] [Abstract][Full Text] [Related]
40. Lipid-based Vehicles for siRNA Delivery in Biomedical Field. Li T; Huang L; Yang M Curr Pharm Biotechnol; 2020; 21(1):3-22. PubMed ID: 31549951 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]